Interestingly, the NR-HCC group showed a tendency of higher expressions of CD9, CD62P, CD42a and CD29 up to 12 months postoperativly compared to the R-HCC group, but these differences were not statistically significant (Fig. 4). This evidence concerns the gene GP9 and hepatocellular carcinoma.